NO20041643L - Farmasoytisk akseptable salter av 20(S)-kamptoteciner - Google Patents

Farmasoytisk akseptable salter av 20(S)-kamptoteciner

Info

Publication number
NO20041643L
NO20041643L NO20041643A NO20041643A NO20041643L NO 20041643 L NO20041643 L NO 20041643L NO 20041643 A NO20041643 A NO 20041643A NO 20041643 A NO20041643 A NO 20041643A NO 20041643 L NO20041643 L NO 20041643L
Authority
NO
Norway
Prior art keywords
sub
acid
sup
pharmaceutically acceptable
acceptable salts
Prior art date
Application number
NO20041643A
Other languages
English (en)
Inventor
Sairam Pothukuchi
Subrahmanyam Duvvury
Sriram Rajagopal
Original Assignee
Reddys Lab Ltd Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddys Lab Ltd Dr filed Critical Reddys Lab Ltd Dr
Publication of NO20041643L publication Critical patent/NO20041643L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
NO20041643A 2001-09-25 2004-04-22 Farmasoytisk akseptable salter av 20(S)-kamptoteciner NO20041643L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN798MA2001 2001-09-25
PCT/IB2002/003950 WO2003027118A1 (en) 2001-09-25 2002-09-25 Pharmaceutically acceptable salts of 20(s)-camptothecins

Publications (1)

Publication Number Publication Date
NO20041643L true NO20041643L (no) 2004-04-22

Family

ID=33042623

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20041643A NO20041643L (no) 2001-09-25 2004-04-22 Farmasoytisk akseptable salter av 20(S)-kamptoteciner

Country Status (18)

Country Link
US (1) US7071203B2 (no)
EP (1) EP1430059B1 (no)
JP (1) JP2005507893A (no)
KR (1) KR20040039404A (no)
CN (1) CN1575292A (no)
AT (1) ATE318823T1 (no)
BR (1) BR0212990A (no)
CA (1) CA2461089A1 (no)
DE (1) DE60209517D1 (no)
HU (1) HUP0401912A3 (no)
IL (1) IL160982A0 (no)
MX (1) MXPA04002784A (no)
NO (1) NO20041643L (no)
NZ (1) NZ531878A (no)
PL (1) PL368229A1 (no)
RU (1) RU2004109163A (no)
WO (1) WO2003027118A1 (no)
ZA (1) ZA200402321B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003068778A1 (en) * 2002-02-18 2003-08-21 Dr. Reddy's Laboratories Limited A process for the preparation of 10-hydroxy-9-n,n-dimethylaminomethyl-5-(2'-fluoroethoxy)-20(s)-camptothecin hydrochloride
TWI333492B (en) * 2003-11-12 2010-11-21 Smithkline Beecham Cork Ltd Crystalline topotecan hydrochloride product and preparation thereof
WO2006038526A1 (ja) * 2004-10-01 2006-04-13 Kabushiki Kaisha Yakult Honsha イリノテカン酸付加塩
ITMI20061473A1 (it) * 2006-07-26 2008-01-27 Indena Spa Derivati della camptotecina ad attivita antitumorale

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1025029C (zh) * 1988-10-22 1994-06-15 沈阳药学院 喜树硷精氨酸盐制剂的制备方法
US6177439B1 (en) * 1995-06-06 2001-01-23 Reddy's Research Foundation Water soluble analogues of 20(S)-camptothecin
JP4094710B2 (ja) * 1997-11-06 2008-06-04 株式会社ヤクルト本社 新規なカンプトテシン誘導体

Also Published As

Publication number Publication date
BR0212990A (pt) 2004-09-21
CN1575292A (zh) 2005-02-02
NZ531878A (en) 2006-04-28
KR20040039404A (ko) 2004-05-10
ZA200402321B (en) 2005-01-13
HUP0401912A2 (hu) 2005-01-28
RU2004109163A (ru) 2005-10-10
US7071203B2 (en) 2006-07-04
ATE318823T1 (de) 2006-03-15
PL368229A1 (en) 2005-03-21
WO2003027118A1 (en) 2003-04-03
DE60209517D1 (de) 2006-04-27
MXPA04002784A (es) 2004-07-29
EP1430059B1 (en) 2006-03-01
IL160982A0 (en) 2004-08-31
EP1430059A1 (en) 2004-06-23
CA2461089A1 (en) 2003-04-03
JP2005507893A (ja) 2005-03-24
HUP0401912A3 (en) 2007-02-28
US20040198760A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
FR18C1006I2 (fr) Derives de quinoline ayant un groupe azolyle et derives de quinazoline
EP2269975A3 (en) Method for producing aminothiazole derivative and production intermediate
NO20051051L (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme i terapeutiske midler
DK1601653T3 (da) Fremgangsmåde til fremstilling af substituerede nikotinsyreestre
NO20051009L (no) Syntese av indoliziner
NO20041643L (no) Farmasoytisk akseptable salter av 20(S)-kamptoteciner
DE60006857D1 (de) Verfahren zur herstellung von pyridinmethanol-verbindungen
WO2001089447A8 (en) Antifungal substituted propyl triazole compound, its salt, and preparation methods thereof
NO20033131L (no) Anvendelse av 2-amino-4-pyridylmetyl-tiazolinderivater som inhibitorer forinduktibel NO-syntase
BR0307008A (pt) N-aril-4,5-dia-minopirazóis e agentes de tingimento que contêm esses compostos
NO330965B1 (no) Fremgangsmate for fremstilling av substituerte imidazolderivater, mellomprodukter anvendt i fremgangsmaten samt fremgangsmate for fremstilling av mellomprodukt
EE200300090A (et) Asendatud imidasopüridiinühendite valmistamise meetod
AR036680A1 (es) Procedimiento para preparar derivados de heterocicloalquilsulfonilpirazol y compuestos utiles en su preparacion
NO20002497L (no) Fremgangsmåte for fremstilling av hydroksyforbindelser
DK1296965T3 (da) Fremgangsmåde til fremstilling af 4-brom-anilinderivater
IT1271703B (it) "derivati 6-o 7-sostituiti del 4-aminoandrostadienone e procedimento per la loro preparazione"
NO20062187L (no) Furanderivat som EP4-reseptorantagonister